WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030771    International Application No.:    PCT/JP2000/007584
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    28.05.2001    
C07D 277/34 (2006.01)
Applicants: KYOWA HAKKO KOGYO CO., LTD. [JP/JP]; 6-1, Ohtemachi 1-chome, Chiyoda-ku, Tokyo 100-8185 (JP) (For All Designated States Except US).
AKAMA, Tsutomu [JP/US]; (US) (For US Only).
KANDA, Yutaka [JP/JP]; (JP) (For US Only).
ASAI, Akira [JP/JP]; (JP) (For US Only).
YAMASHITA, Yoshinori [JP/JP]; (JP) (For US Only).
KITAMURA, Yushi [JP/JP]; (JP) (For US Only).
MURAKATA, Chikara [JP/JP]; (JP) (For US Only).
KOMATSU, Kazunori [JP/JP]; (JP) (For US Only).
KISHIKAWA, Kuniyuki [JP/JP]; (JP) (For US Only).
KOBAYASHI, Yumiko [JP/JP]; (JP) (For US Only).
SASHO, Setsuya [JP/JP]; (JP) (For US Only)
Inventors: AKAMA, Tsutomu; (US).
KANDA, Yutaka; (JP).
ASAI, Akira; (JP).
YAMASHITA, Yoshinori; (JP).
KITAMURA, Yushi; (JP).
MURAKATA, Chikara; (JP).
KOMATSU, Kazunori; (JP).
KISHIKAWA, Kuniyuki; (JP).
KOBAYASHI, Yumiko; (JP).
SASHO, Setsuya; (JP)
Priority Data:
11/307575 28.10.1999 JP
Abstract: front page image
(EN)Thiazolidinedione derivatives of the general formula (I) or pharmacologically acceptable salts thereof, exhibiting a telomerase-inhibiting effect, wherein R1a and R1b are each hydrogen, lower alkyl, or the like; r1 and r2 are each a single or double bond; and X is a group of the general formula (II) [wherein Y is NR2 (wherein R2 is hydrogen, lower alkyl, or the like) or the like] or the like..
(FR)L'invention concerne des dérivés de thiazolidinédione de formule générale (I), ou des sels de ceux-ci pharmaceutiquement acceptables, qui présentent un effet inhibant la télomérase. R1a et R1b représentent chacun hydrogène, alkyle faible, ou analogue; r1 et r2 représentent chacun une liaison simple ou double; et X représente un groupe de formule générale (II), [dans laquelle Y représente NR2 (R2 représentant hydrogène, ou analogue) ou analogue] ou analogue.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)